Michael R. Megna - 01 Apr 2025 Form 4 Insider Report for Kiniksa Pharmaceuticals International, plc (KNSA)

Role
CHIEF ACCOUNTING OFFICER
Signature
/s/ Madelyn Zeylikman, Attorney-in-Fact
Issuer symbol
KNSA
Transactions as of
01 Apr 2025
Net transactions value
-$45,369
Form type
4
Filing time
03 Apr 2025, 16:52:16 UTC
Previous filing
19 Mar 2025
Next filing
09 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KNSA Class A Ordinary Share Options Exercise +2,557 +9.3% 30,000 01 Apr 2025 Direct F1
transaction KNSA Class A Ordinary Share Options Exercise +2,363 +7.9% 32,363 01 Apr 2025 Direct F1
transaction KNSA Class A Ordinary Share Tax liability $23,577 -1,083 -3.3% $21.77 31,280 01 Apr 2025 Direct
transaction KNSA Class A Ordinary Share Tax liability $21,792 -1,001 -3.2% $21.77 30,279 01 Apr 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KNSA Share Option Award $0 +21,150 $0.000000 21,150 01 Apr 2025 Class A Ordinary Share 21,150 $21.77 Direct F2
transaction KNSA Restricted Share Unit Award $0 +10,575 $0.000000 10,575 01 Apr 2025 Class A Ordinary Share 10,575 Direct F1, F3
transaction KNSA Restricted Share Unit Options Exercise $0 -2,557 -33% $0.000000 5,115 01 Apr 2025 Class A Ordinary Share 2,557 Direct F1, F4
transaction KNSA Restricted Share Unit Options Exercise $0 -2,363 -25% $0.000000 7,087 01 Apr 2025 Class A Ordinary Share 2,363 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.
F2 The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 1, 2025.
F3 The RSUs vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 1, 2025.
F4 The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 1, 2023.
F5 The RSUs vest over a four-year period, with 25% of the RSUs vesting on the vesting commencement date of April 1, 2024, and each yearly anniversary thereafter.